PharmaRosa® NEONATAL – Partner programmes

Connecting stakeholders. Providing structure.

The garden rose sector is transforming: the wide range of varieties, labour and cost pressures, together with the need for reliable supply, are increasingly directing the market towards own-rooted, schedulable and traceable solutions. PharmaRosa® NEONATAL is the starting point of this system: batch-identified, own-rooted propagation material that makes the entire product pathway more predictable.

Shared technological benefits (for all stakeholders)

• No rootstock–scion “split” energy, no budding/grafting weak point.
• More uniform plant performance and regeneration potential – more predictable responses in the production technology.
• Possibility of shorter cycles (by eliminating rootstock-raising time), with fewer risk points.

Stakeholder-specific benefits

• Grower: more predictable scheduling and more uniform batches → more stable cost control.
• Reseller: more uniform shelf appearance and more predictable supply → fewer complaints, better turnover.
• Breeder: batch-identified pathway and documentation → simpler maintenance and control.
• Collector: variety preservation and knowledge sharing with a stable background.
• Designer/public space: long-term stand stability and lower replacement risk.

To the technological backbone of NEONATAL: What is NEONATAL? Technology (overview)

1) Select your role and objective

• Production, resale, variety introduction, variety preservation or design project?

2) Choose the technological route (A/B/C/D)

• A (plastic tunnel) – fast cycle
• B (cold house) – compact, hardened
• C (open field) – robust
• D (arable field) – commercial-scale scheduling

3) Risk reduction: trial cycle

• 5–10 varieties, 1 tray per variety; one pathway; the aim is to validate your own substrate–irrigation–climate combination.

Ordering information: Information Collection Payment